Moreira V, San Román A L, Meroño E, Arribas R, Herrero C, Defarges V, García M
Departamento de Medicina, Universidad de Alcalá de Henares.
Rev Clin Esp. 1992 Apr;190(7):344-8.
Endoscopic sphincterotomy is widely accepted as the technique of choice in the treatment of residual or recidivant choledocholithiasis since the results obtained with this technique are favorable when compared to biliary surgery in most series. However, the experience of long term follow up of patients with choledocholithiasis in whom this technique would have been applied as the only treatment is still scarce up to date. We have studied 40 patients (mean age 65.6 +/- 11.1 years) with residual or recidivant choledocholithiasis who had undergone endoscopic treatment successfully before the 30th of June 1985, who could be contacted by a mailed questionnaire or by phone by August 1990. The follow up time 70.7 +/- 19.4 months (mean +/- typical deviation). Out of them, 36 (90%) had been asymptomatic up to the contact date (30 cases) or up to death due to causes not related to biliary pathology (6 patients). Out of the 4 remaining patients, 2 presented mild dyspepsia and another patient has probably developed recidivant choledocholithiasis (according to I.V. cholangiography). The fourth patient presented a severe episode of cholangitis and acute pancreatitis, related to a new episode of choledocholithiasis and died 5 and a half years after the endoscopic sphincterectomy. This represents a 2.5% mortality. These long term results of endoscopic sphincterotomy in patients with residual or recidivant choledocholithiasis are an other point in favour of using this technique as the single treatment of choice in patients above 60 years old.
内镜括约肌切开术被广泛认为是治疗残余或复发性胆总管结石的首选技术,因为在大多数系列研究中,与胆道手术相比,该技术取得的效果良好。然而,迄今为止,关于仅采用该技术治疗胆总管结石患者的长期随访经验仍然很少。我们研究了40例(平均年龄65.6±11.1岁)残余或复发性胆总管结石患者,这些患者在1985年6月30日前成功接受了内镜治疗,到1990年8月可以通过邮寄问卷或电话联系到他们。随访时间为70.7±19.4个月(平均±标准差)。其中,36例(90%)在联系时(30例)或因与胆道疾病无关的原因死亡时(6例)无症状。其余4例患者中,2例出现轻度消化不良,另1例可能复发了胆总管结石(根据静脉胆管造影)。第4例患者发生了严重的胆管炎和急性胰腺炎,与胆总管结石复发有关,在内镜括约肌切除术后5年半死亡。这代表着2.5%的死亡率。内镜括约肌切开术治疗残余或复发性胆总管结石的这些长期结果是支持将该技术作为60岁以上患者单一治疗选择的又一依据。